XW043M7 Introduction of Brexucabtagene Autoleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7
Section: New Technology
Body system: Anatomical Regions
Operation: Introduction — Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products